Mike Sherman is the founder of Chimerix. Chimerix has raised $840M in total funding. Funding history, background and contact routes on StartupFundraising.com.
Mike Sherman has over 30 years of experience in the life sciences industry, serving as CEO and Board Director for several public and private companies. He led Chimerix through a strategic transformation to oncology drug development, culminating in a $935 million acquisition by Jazz Pharmaceuticals. Previously, he led Endocyte to a $2.1 billion acquisition by Novartis.
Full founder directory · Investor directory · Company funding database · Fundraising library